Impaired insulin-mediated vasorelaxation in diabetic Goto-Kakizaki rats is caused by impaired Akt phosphorylation

American Journal of Physiology - Cell Physiology

Volumn 296, Issue 2, 2009, Pages

  Lee, Jin Hee ^a,b   Palaia, Thomas ^a   Ragolia, Louis ^a,b  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Akt; Diabetes; Inducible nitric oxide synthase; Insulin; Vasodilation

Indexed keywords

ANGIOTENSIN II; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; MYOSIN LIGHT CHAIN; NITRATE; NITRITE; PROTEIN KINASE B; SURVIVIN;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; GOTO KAKIZAKI RAT; INSULIN SENSITIVITY; MALE; MYOGRAPHY; NITROSYLATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; STIMULATION; VASCULAR SMOOTH MUSCLE; VASCULARIZATION; VASODILATATION; WISTAR KYOTO RAT;

ADENOVIRIDAE; ANGIOTENSIN II; ANIMALS; AORTA; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; GENETIC VECTORS; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MUSCLE, SMOOTH, VASCULAR; MYOGRAPHY; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHORYLATION; PROTEIN PHOSPHATASE 1; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, INBRED WKY; RECOMBINANT PROTEINS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSFECTION; VASOCONSTRICTION; VASODILATION;

ADENOVIRIDAE; RATTUS;

EID: 60849088880     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00254.2008     Document Type: Article

References (90)

1. Abu-Lebdeh H, Hodge D, Nguyen T. Predictors of macrovascular disease in patients with Type 2 diabetes mellitus. Mayo Clin Proc 76: 707-712, 2001.
2. Aizawa Y, Kawabe Ji Hasebe N, Takehara N, Kikuchi K. Pioglitazone enhances cytokine-induced apoptosis in vascular smooth muscle cells and reduces intimal hyperplasia. Circulation 104: 455-460, 2001.
3. Alessi D, MacDougall L, Sola M, Ikebe M, Cohen P. The control of protein phosphatase-1 by targetting subunits. Eur J Biochem 210: 1023-1035, 1992.
4. Allen R, Krueger K, Dhume A, Agrawal D. Sustained Akt/PKB activation and transient attenuation of c-jun N-terminal kinase in the inhibition of apoptosis by IGF-1 in vascular smooth muscle cells. Apoptosis 10:525-535, 2005.
5. Amaravadi R, Thompson CB. The survival kinases Akt and Pim as potential pharmacological targets. J Clin Invest 115: 2618-2624, 2005.
6. Anderson RD, Haskell RE, Xia H, Roessler BJ, Davidson L. A simple method for the rapid generation of recombinant adenovirus vectors. Gene Therapy 7: 1034-1038, 2000.
7. Bae SS, Cho H, Mu J, Birnbaum MJ. Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B. J Biol Chem 278: 49530-49536, 2003.
8. Begum N, Duddy N, Sandu O, Reinzie J, Ragolia L. Regulation of myosin-bound protein phosphatase by insulin in vascular smooth muscle cells: evaluation of the role of Rho kinase and phosphatidylinositol-3-kinase-dependent signaling pathways. Mol Endocrinol 14: 1365-1376, 2000.
9. Begum N, Ragolia L, Rienzie J, McCarthy M, Duddy N. Regulation of mitogen-activated protein kinase phosphatase-1 induction by insulin in vascular smooth muscle cells. Evaluation of the role of the nitric oxide signaling pathway and potential defects in hypertension. J Biol Chem 273: 25164-25170, 1998.
10. Begum N, Sandu OA, Duddy N. Negative regulation of Rho signaling by insulin and its impact on actin cytoskeleton organization in vascular smooth muscle cells: role of nitric oxide and cyclic guanosine monophos- phate signaling pathways. Diabetes 51: 2256-2263, 2002.
11. Begum N, Sandu OA, Ito M, Lohmann SM, Smolenski A. Active Rho kinase (ROK-alpha) associates with insulin receptor substrate-1 and inhibits insulin signaling in vascular smooth muscle cells. J Biol Chem 277:6214-6222, 2002.
12. Blanc-Brude O, Yu J, Simosa H, Conte M, Sessa W, Altieri D. Inhibitor of apoptosis protein survivin regulates vascular injury. Nat Med 8: 987-994, 2002.
13. Cain A, Khalil R. Pathophysiology of essential hypertension: role of the pump, the vessel, and the kidney. Semin Nephrol 22: 3-16, 2002.
14. Carmo A, Cunha-Vaz J, Carvalho A, Lopes M. Nitric oxide synthase activity in retinas from non-insulin-dependent diabetic Goto-Kakizaki rats: correlation with blood-retinal barrier permeability. Nitric Oxide 4:590-596, 2000.
15. Carvalho-Filho MA, Ueno M, Hirabara SM, Seabra AB, Carvalheira JBC, de Oliveira MG, Velloso LA, Curi R, Saad MJA. S-Nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: a novel mechanism of insulin resistance. Diabetes 54: 959 -967, 2005.
16. Ceriello A, Motz E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited. Arterioscler Thromb Vasc Biol 24: 816-823, 2004.
17. Chen LW, Chang WJ, Wang JS, Hsu CM. Thermal injury-induced peroxynitrite production and pulmonary inducible nitric oxide synthase expression depend on JNK/AP-1 signaling. Critical Care Med 34: 142-150, 2006.
18. Cheng Z, Gronholm T, Louhelainen M, Finckenberg P, Merasto S, Tikkanen I, Mervaala E. Vascular and renal effects of vasopeptidase inhibition and angiotensin-converting enzyme blockade in spontaneously diabetic Goto-Kakizaki rats. J Hypertens 23: 1757-1770, 2005.
19. Chung H, Pae H, Choi B, Billiar T, Kim Y. Nitric oxide as a bioregulator of apoptosis. Biochem Biophys Res Commun 282: 1075-1079, 2001.
20. Eguchi S, Iwasaki H, Ueno H, Frank GD, Motley ED, Eguchi K, Marumo F, Hirata Y, Inagami T. Intracellular signaling of angiotensin II-induced p70 S6 kinase phosphorylation at Ser411 in vascular smooth muscle cells. Possible requirement of epidermal growth factor receptor, ras, extracellular signal-regulated kinase, and Akt. J Biol Chem 274:36843-36851, 1999.
21. Eguchi S, TI. Signal transduction of angiotensin II type 1 receptor through receptor tyrosine kinase. Regul Pept 91: 13-20, 2000.
22. Elgebaly M, Kelly A, Harris A, Elewa H, Portik-Dobos V, Ketsawat- somkron P, Marrero M, Ergul A. Impaired insulin-mediated vasorelaxation in a nonobese model of Type 2 diabetes: role of endothelin-1. Can J Physiol Pharmacol 86: 358-364, 2008.
23. Elizalde M, Ryden M, van Harmelen V, Eneroth P, Gyllenhammar H, Holm C, Ramel S, Olund A, Arner P, Andersson K. Expression of nitric oxide synthases in subcutaneous adipose tissue of nonobese and obese humans. J Lipid Res 41:1244-1251, 2000.
24. Engels K, Knauer SK, Loibl S, Fetz V, Harter P, Schweitzer A, Fisseler-Eckhoff A, Kommoss F, Hanker L, Nekljudova V, Hermanns I, Kleinert H, Mann W, du Bois A, Stauber RH. NO signaling confers cytoprotectivity through the survivin network in ovarian carcinomas. Cancer Res 68: 5159-5166, 2008.
25. Farese RV, Sajan MP, Standaert ML. Insulin-sensitive protein kinases (atypical protein kinase C and protein kinase B/Akt): Actions and defects in obesity and Type II diabetes. Exp Biol Med 230: 593-605, 2005.
26. Feliers D, Duraisamy S, Faulkner J, Duch J, Lee A, Abboud H, Choudhury G, Kasinath B. Activation of renal signaling pathways in db/db mice with Type 2 diabetes. Kidney Int 60: 495-504, 2001.
27. Feng J, Ito M, Ichikawa K, Isaka N, Nishikawa M, Hartshorne DJ, Nakano T. Inhibitory phosphorylation site for Rho-associated kinase on smooth muscle myosin phosphatase. J Biol Chem 274:7385-37390, 1999.
28. Folli F, Kahn CR, Hansen H, Bouchie JL, Feener EP. Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk. J Clin Invest 100: 2158-2169, 1997.
29. Folli F, Saad M, Velloso L, Hansen H, Carandente O, Feener E, Kahn C. Crosstalk between insulin and angiotensin II signalling systems. Exp Clin Endocrinol Diabetes 107: 133-139, 1999.
30. Garofalo RS, Orena SJ, Rafidi K, Torchia AJ, Stock JL, Hildebrandt AL, Coskran T, Black SC, Brees DJ, Wicks JR, McNeish JD, Coleman KG. Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKBβ. J Clin Invest 112: 19-208, 2003.
31. Goto Y, Kakizaki M, Masaki N. Production of spontaneous diabetic rats by repetition of sensitive breeding. Tokoku J Exp Med 119: 85-90, 1976.
32. Hartshorne DJ. Physiology of The Gastrointestinal Tract, edited by Johnson DR. New York: Raven, 1987, p. 423-482.
33. Ikebe M, Hartshorne D. Phosphorylation of smooth muscle myosin at two distinct sites by myosin light chain kinase. J Biol Chem 260: 10027-10031, 1985.
34. Ikebe M, Hartshorne D, Elzinga M. Identification, phosphorylation, and dephosphorylation of a second site for myosin light chain kinase on the 20,000-dalton light chain of smooth muscle myosin. J Biol Chem 261: 36-39, 1986.
35. Ikeguchi M, Ueta T, Yamane Y, Hirooka Y, Kaibara N. Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma. Clin Cancer Res 8: 3131-3136, 2002.
36. Isenovic ER, Meng Y, Divald A, Milivojevic N, Sowers JR. Role of phosphatidylinositol 3-kinase/Akt pathway in angiotensin II and insulinlike growth factor-1 modulation of nitric oxide synthase in vascular smooth muscle cells. Endocrine 19: 287-292, 2002.
37. Jacob A, Smolenski A, Lohmann SM, Begum N. MKP-1 expression and stabilization and cGK Iα prevent diabetes-associated abnormalities in VSMC migration. Am J Physiol Cell Physiol 287: C1077-C1086, 2004.
38. Kahn AM, Husid A, Allen JC, Seidel CL, Song T. Insulin acutely inhibits cultured vascular smooth muscle cell contraction by a nitric oxide synthase-dependent pathway. Hypertension 30: 928 -933, 1997.
39. Kamm K, Stull J. The function of myosin and myosin light chain kinase phosphorylation in smooth muscle. Ann Rev Pharmacol Toxicol 25: 593, 1985.
40. Kapur S, Bedard S, Marcotte B, Cote C, Marette A. Expression of nitric oxide synthase in skeletal muscle: a novel role for nitric oxide as a modulator of insulin action. Diabetes 46: 1691-1700, 1997.
41. 2+]i signaling. Am J Physiol Regul Integr Comp Physiol 290: R145-R153, 2006.
42. Katome T, Obata T, Matsushima R, Masuyama N, Cantley LC, Gotoh Y, Kishi K, Shiota H, Ebina Y. Use of RNA interference-mediated gene silencing and adenoviral overexpression to elucidate the roles of AKT/ protein kinase B isoforms in insulin actions. J Biol Chem 278: 28312-28323, 2003.
43. Kim Y, Nikoulina S, Ciaraldi T, Henry R, Kahn B. Normal insulin- dependent activation of Akt/potein kinase B, with diminished activation of phosphoinositide 3 kinase, in muscle in type2 diabetes. J Clin Invest 104:733-741, 1999.
44. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, Yamamori B, Feng J, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 273: 245-248, 1996.
45. Kreiling JL, Byrd JC, MacDonald RG. Domain interactions of the mannose 6-phosphate/insulin-like growth factor II receptor. J Biol Chem 280: 21067-21077, 2005.
46. Krook A, Kawano Y, Song X, Efecdic S, Roth R, Wallberg-Henriksson H, Zierath J. Improved glucose tolerance restores insulin-stimulated Akt kinase activity and glucose transporter in skeletal muscle from diabetic Goto-Kakizaki rats. Diabetes 46: 2110-2114, 1997.
47. Krook A, Roth R, Jiang X, Zierath J, and Wallberg-Henriksson H. Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects. Diabetes 47: 1281-1286, 1998.
48. Lee JH, Ragolia L. AKT phosphorylation is essential for insulin-induced relaxation of rat vascular smooth muscle cells. Am J Physiol Cell Physiol 291: C1355-C1365, 2006.
49. Lee JH, Xia S, Ragolia L. Upregulation of AT2 receptor and iNOS impairs angiotensin II-induced contraction without endothelium influence in young normotensive diabetic rats. Am J Physiol Regul Integr Comp Physiol 295: R144-R154, 2008.
50. 2. Am J Physiol Heart Circ Physiol 288: H2306-H2316, 2005.
51. Li F, Malik KU. Angiotensin II-induced Akt activation through the epidermal growth factor receptor in vascular smooth muscle cells is mediated by phospholipid metabolites derived by activation of phospholipase D. J Pharmacol Exp Ther 312: 1043-1054, 2005.
52. Ludmer P, Selwyn A, Shook T, Wayne R, Mudge G, Alexander R, Ganz P. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 315: 1046-1051, 1986.
53. Luo Z, Fujio Y, Kureishi Y, Rudic R, Daumerie G, Fulton D, Sessa W, Walsh K. Acute modulation of endothelial Akt/PKB activity alters nitric oxide- dependent vasomotor activity in vivo. J Clin Invest 106: 493-499, 2000.
54. Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA, Kaiser N, Halban PA, Donath MY. Glucose-induced β cell production of IL-β contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110: 851-860, 2002.
55. Martin E, Nathan C, Xie QW. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J Exp Med 180: 977-984, 1994.
56. Mita AC, Mita MM, Nawrocki ST, Giles FJ. Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clin Cancer Res 14: 5000-5005, 2008.
57. Nadler ST, Stoehr JP, Rabaglia ME, Schueler KL, Birnbaum MJ, Attie AD. Normal Akt/PKB with reduced PI3K activation in insulin- resistant mice. Am J Physiol Endocrinol Metab 281: E1249-E1254, 2001.
58. Oeckler RA, Kaminski PM, Wolin MS. Stretch enhances contraction of bovine coronary arteries via an NAD(P)H oxidase-mediated activation of the extracellular signal-regulated kinase mitogen-activated protein kinase cascade. Circ Res 92: 23-31, 2003.
59. Ohashi H, Takagi H, Oh H, Suzuma K, Suzuma I, Miyamoto N, Uemura A, Watanabe D, Murakami T, Sugaya T, Fukamizu A, Honda Y. Phosphatidylinositol 3-kinase/Akt regulates angiotensin II-induced inhibition of apoptosis in microvascular endothelial cells by governing survivin expression and suppression of caspase-3 activity. Circ Res 94: 785-793, 2004.
60. Okon E, Szado T, Laher I, McManus B, van Breemen C. Augmented contractile response of vascular smooth muscle in a diabetic mouse model. J Vasc Res 40: 520-530, 2003.
61. Ortiz PA, Garvin JL. Cardiovascular and renal control in NOS-deficient mouse models. Am J Physiol Regul Integr Comp Physiol 284: R628-R638, 2003.
62. Perreault M, Marette A. Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat Med 7: 1138-1143, 2001.
63. Potenza MA, Marasciulo FL, Chieppa DM, Brigiani GS, Formoso G, Quon MJ, Montagnani M. Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production. Am J Physiol Heart Circ Physiol 289: H813-H822, 2005.
64. Ragolia L, Palaia T, Koutrouby TB, Maesaka JK. Inhibition of cell cycle progression and migration of vascular smooth muscle cells by prostaglandin D2 synthase: resistance in diaetic Goto-Kakizaki rats. Am J Physiol Cell Physiol 287: C1273-C1281, 2004.
65. Reaven Banting lecture 1988 GM. Role of insulin resistance in human disease. Diabetes 37: 1595-1607, 1988.
66. Resende A, Tabellion A, Nadaud S, Lartaud I, Bagrel D, Faure S, Atkinson J, and Capdeville-Atkinson C. Incubation of rat aortic rings produces a specific reduction in agonist-evoked contraction: effect of age of donor. Life Sci 76: 9-20, 2004.
67. Rey FE, Li XC, Carretero OA, Garvin JL, Pagano PJ. Perivascular superoxide anion contributes to impairment of endothelium-dependent relaxation: Role of gp91phox. Circulation 106: 2497-2502, 2002.
68. Ribeiro D, Kitakawa D, Domingues M, Cabral L, Marques M, Salvadori D. Survivin and inducible nitric oxide synthase production during 4NQO-induced rat tongue carcinogenesis: a possible relationship. Exp Mol Pathol 83: 131-137, 2007.
69. Rondinone CM, Carvalho E, Wesslau C, Smith U. Impaired glucose transport and protein kinase B activation in insulin, but not okadaic acid, in adipocytes from subjects with type II diabetic mellitus. Diabetologia 42: 819-825, 1999.
70. Sable CL, Filippa N, Hemmings B, Van Obberghen E. cAMP stimulates protein kinase B in a Wortmannin-insensitive manner. FEBS Lett 409: 253-257, 1997.
71. Salehi A, Abaraviciene SM, Jimenez-Feltstrom J, Ostenson CG, Efendic S, Lundquist3 I. Excessive islet NO generation in Type 2 diabetic GK rats coincides with abnormal hormone secretion and is counteracted by GLP-1. PLoS ONE 3: e2165, 2008.
72. Sandu O, Ragolia L, Begum N. Diabetes in the Goto-Kakizaki rat is accompanied by impaired insulin-mediated myosin-bound phosphatase activation and vascular smooth muscle cell relaxation. Diabetes 49:2178 -2189, 2000.
73. Sandu OA, Ito M, Begum N. Signal transduction in smooth muscle: selected contribution: insulin utilizes NO/cGMP pathway to activate myosin phosphatase via Rho inhibition in vascular smooth muscle. J Appl Physiol 91: 1475-1482, 2001.
74. Sandu OA, Ragolia L, Begum N. Diabetes in the Goto-Kakizaki rat is accompanied by impaired insulin-mediated myosin-bound phosphatase activation and vascular smooth muscle cell relaxation. Diabetes 49:2178 -2189, 2000.
75. Schini-Kerth V, Vanhoutte P. Nitric oxide synthases in vascular cells. Exp Physiol 80: 885-905, 1995.
76. Shimabukuro M, Higa M, Zhou YT, Wang MY, Newgard CB, Unger RH. Lipoapoptosis in Beta-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression. J Biol Chem 273: 32487-32490, 1998.
77. Sowers JR. Insulin resistance and hypertension. Am J Physiol Heart Circ Physiol 286: H1597-H1602, 2004.
78. Steinberg H, Brechtel G, Johnson A, Fineberg N, Baron A. Insulin- mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 94: 1172-1179, 1994.
79. Sugita H, Kaneki M, Tokunaga E, Sugita M, Koike C, Yasuhara S, Tompkins RG, Martyn JAJ. Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance. Am J Physiol Endocrinol Metab 282: E386-E394, 2002.
80. Taniyama Y, Ushio-Fukai M, Hitomi H, Rocic P, Kingsley MJ, Pfahnl C, Weber DS, Alexander RW, Griendling KK. Role of p38 MAPK and MAPKAPK-2 in angiotensin II-induced Akt activation in vascular smooth muscle cells. Am J Physiol Cell Physiol 287: C494-C499, 2004.
81. Tannous M, Rabini R, Vignini A, Moretti N, Fumelli P, Zielinski B, Mazzanti L, Mutus B. Evidence for iNOS-dependent peroxynitrite production in diabetic platelets. Diabetologia 42:539-544, 1999.
82. Torres SH, De Sanctis JB, de Briceno LM, Hernandez N, Finol HJ. Inflammation and nitric oxide production in skeletal muscle of Type 2 diabetic patients. J Endocrinol 181: 419-427, 2004.
83. Velloso L, Folli F, Perego L, Saad M. The multi-faceted cross-talk between the insulin and angiotensin II signaling systems. Diabetes Metab Res Rev 22: 98 -107, 2006.
84. Walia M, Samson SE, Schmidt T, Best K, Whittington M, Kwan CY, Grover AK. Peroxynitrite and nitric oxide differ in their effects on pig coronary artery smooth muscle. Am J Physiol Cell Physiol 284: C649 -C657, 2003.
85. Wang J, Yang L, Yang J, Kuropatwinski K, Wang W, Liu XQ, Hauser J, Brattain MG. Transforming growth factor β induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/Survivin pathway in colon cancer cells. Cancer Res 68: 3152-3160, 2008.
86. Wink D, Miranda K, Espey M. Effects of oxidative and nitrosative stress in cytotoxicity. Semin Perinatol 24: 20 -23, 2000.
87. Yasukawa T, Tokunaga E, Ota H, Sugita H, Martyn JAJ, Kaneki M. S-Nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance. J Biol Chem 280: 7511-7518, 2005.
88. Yasukawa T, Tokunaga E, Ota H, Sugita H, Martyn JAJ, Kaneki M. S-Nitrosylation-dependent Inactivation of Akt/Protein Kinase B in Insulin Resistance. J Biol Chem 280: 7511-7518, 2005.
89. Zemel MD, Reddy S, Sowers. JR. Insulin attenuation of vasoconstrictor responses to phenylephrine in Zucker lean and obese rats. Am J Hypertens 4: 537-539, 1991.
90. Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L, Unger RH. Lipotoxic heart disease in obese rats: Implications for human obesity. Proc Natl Acad Sci USA 97: 1784-1789, 2000.